Stock Trading

An insider is legally permitted to buy and sell shares of the firm – and any subsidiaries – that employs him or her. However, these transactions must be properly registered with the Securities and Exchange Commission (SEC) and are done with advance filings. You can find details of this type of insider trading on the SEC’s EDGAR database. This algorithmic forecast is for stocks with recently reported insiders’ transactions.An “insider” is any person who possesses at least one of the following:

• access to valuable non-public information about a corporation (for example a company’s directors and high-level executives)
• ownership of more than 10% of the company’s equity

Package Name: Insiders Stocks
Recommended Positions: Long
Forecast Length: 1 Month (11/12/2017 – 12/12/2017)
I Know First Average: 12.94%

For this 1 Month forecast the algorithm had successfully predicted 9 out of 10 movements. The highest trade return came from NKTR, at 68.83%. The suggested trades for ORLY and TTI also had notable 1 Month yields of 15.12% and 12.36%, respectively. The overall average return in this Insiders Stocks package was 12.94%, providing investors with a 9.77% premium over the S&P 500’s return of 3.17% during the same period.

Nektar Therapeutics (NKTR), develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. Its product pipeline includes drug candidates in therapeutic areas comprising cancer, auto-immune disease, and chronic pain.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.